Current approaches to primary therapy for papillary and follicular thyroid cancer
EL Mazzaferri, RT Kloos - The Journal of Clinical Endocrinology …, 2001 - academic.oup.com
Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer (DTC),
is … Instead, clinicians rely on large patient cohort studies in which therapy has not been …
is … Instead, clinicians rely on large patient cohort studies in which therapy has not been …
[HTML][HTML] New therapies for dedifferentiated papillary thyroid cancer
… the limited role of radioiodine for dedifferentiated thyroid cancer, call for further efforts in
the … of targeted therapies in the approach of dedifferentiated papillary thyroid cancer (DePTC). …
the … of targeted therapies in the approach of dedifferentiated papillary thyroid cancer (DePTC). …
Papillary thyroid cancer: monitoring and therapy
RM Tuttle, R Leboeuf, AJ Martorella - Endocrinology and metabolism …, 2007 - Elsevier
… cancers) or primary thyroid lymphoma. Within the differentiated thyroid cancer family,
papillary thyroid cancer … with follicular thyroid cancer [3]. Analysis of 15,698 patients who had …
papillary thyroid cancer … with follicular thyroid cancer [3]. Analysis of 15,698 patients who had …
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
EL Mazzaferri, SM Jhiang - The American journal of medicine, 1994 - Elsevier
… Following 131 I therapy given only to ablate normal thyroid gland remnants, … thyroid hormone
therapy alone (P <0.001). No patient treated in this way with 131 I has died of thyroid cancer…
therapy alone (P <0.001). No patient treated in this way with 131 I has died of thyroid cancer…
[HTML][HTML] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
J Ge, J Wang, H Wang, X Jiang, Q Liao, Q Gong… - … of Cancer, 2020 - ncbi.nlm.nih.gov
… with iodine-131 in papillary thyroid cancer. These findings suggest that this BRAF mutation
may be a predictor of the efficacy of iodine-131 treatment for papillary thyroid cancer. …
may be a predictor of the efficacy of iodine-131 treatment for papillary thyroid cancer. …
The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
J Tang, D Kong, Q Cui, K Wang, D Zhang… - … and therapy, 2018 - Taylor & Francis
… , the incidence of thyroid cancer increased by 211% in the USA, driven mostly by the increase
of papillary thyroid cancer (PTC). With the high incidence of thyroid cancer, mortality rate …
of papillary thyroid cancer (PTC). With the high incidence of thyroid cancer, mortality rate …
Response to therapy of papillary thyroid cancer of known BRAF status
A Kowalska, A Walczyk, A Kowalik… - Clinical …, 2017 - Wiley Online Library
… changes adopted recently by the American Thyroid Association (ATA). This … thyroid cancer.
The BRAF V600E mutation is the most common genetic alteration in papillary thyroid cancer (…
The BRAF V600E mutation is the most common genetic alteration in papillary thyroid cancer (…
[HTML][HTML] Targeted therapy of papillary thyroid cancer: A comprehensive genomic analysis
DA Hescheler, B Riemann, MJM Hartmann… - Frontiers in …, 2021 - frontiersin.org
… Background: A limited number of targeted therapy options exist for papillary thyroid cancer
(PTC) to date. Based on genetic alterations reported by the “The Cancer Genome Atlas (TCGA…
(PTC) to date. Based on genetic alterations reported by the “The Cancer Genome Atlas (TCGA…
Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patients
EL Mazzaferri, RL Young - The American journal of medicine, 1981 - Elsevier
… of papillary thyroid cancer employed in … papillary thyroid cancer during follow-up averaging
about a decade. However, in 84 persons (14.6 percent), of whom five eventually died, cancer …
about a decade. However, in 84 persons (14.6 percent), of whom five eventually died, cancer …
Papillary thyroid cancer
NR Caron, OH Clark - Current treatment options in oncology, 2006 - Springer
… , chemotherapy. This continues to be an area of exciting research for emerging therapy, … or
re-establishing the differentiated features of the thyroid cancer cell, in an effort to optimize the …
re-establishing the differentiated features of the thyroid cancer cell, in an effort to optimize the …
相关搜索
- radioiodine therapy papillary thyroid cancer
- iodine therapy papillary thyroid cancers
- monitoring and therapy papillary thyroid cancer
- targeted therapy papillary thyroid cancer
- braf v600e mutation papillary thyroid cancer
- tert promoter mutations papillary thyroid cancer
- patients with papillary thyroid cancer
- clinicopathological characteristics of papillary thyroid cancer
- intermediate risk papillary thyroid cancer
- management of papillary thyroid cancer
- physician survey study papillary thyroid cancer
- known braf status papillary thyroid cancer
- poorer clinical prognosis papillary thyroid cancer
- molecular diagnostic approaches papillary thyroid cancer
- initial manifestations papillary thyroid cancer
- most aggressive papillary thyroid cancer